deltatrials
Completed NA NCT00440024

The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance

A Single-Blind Study to Assess Benefits of a Controlled Daily Skin Care Regimen on Retinoid Intolerant Patients (Derm 570)

Sponsor: Unilever R&D

Conditions Retinoid Intolerance Sun-Damaged Skin
Interventions Dove Facial Moisturizer Dove Mild Cleanser Tazorac
Updated 7 times since 2017 Last updated: Mar 11, 2020 Started: Feb 28, 2007 Primary completion: Nov 30, 2009 Completion: Nov 30, 2009

Listed as NCT00440024, this NA trial focuses on Retinoid Intolerance and Sun-Damaged Skin and remains completed. Sponsored by Unilever R&D, it has been updated 7 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Apr 2020 — Jan 2021 [monthly]

    Completed NA

  5. Jun 2018 — Apr 2020 [monthly]

    Completed NA

▶ Show 2 earlier versions

  1. Mar 2017 — Jun 2018 [monthly]

    Completed NA

  2. Jan 2017 — Mar 2017 [monthly]

    Completed NA

    First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Unilever R&D
  • University of Michigan
Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Ann Arbor, United States